| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d229a80273f0f893e567d015de2fd442
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6972b4c9eea85beb505b51ed5a19b52b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4027d878728fdfbfd0a173310ca923aa
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_59829b4f6af8ce67eeabdefec7bc6dc3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f21c1009c60308a64b8e7dc0bb989632
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4bcb947f9b8a1363662cc31e450319a3 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-37
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-13 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-37
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-04 |
| filingDate |
2009-07-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_59368951e05d1e77476cf5589c0cbdd0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_418c01860937679bfa1213183430cd1f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_12466909e5ba6080eca970c5ecd3a8cf
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c4133129cdc718deb993c72407df9a37
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4c7e2b62bc36c82d30e7d46d20315f79 |
| publicationDate |
2010-01-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2010003687-A1 |
| titleOfInvention |
Von willebrand factor or factor viii and von willebrand factor for the treatment of coagulopathy induced by inhibitors of thrombocytes |
| abstract |
The present invention relates to a von Willebrand Factor for use in the treatment and/or prevention of a bleeding event associated with a thrombopathy induced by substances inhibiting thrombocytes. Furthermore, the present invention relates to a method of treating and/or preventing a disorder related to a bleeding event associated with a thrombopathy induced by substances inhibiting thrombocytes comprising administering a pharmaceutically effective amount of a von-Willebrand- Factor (vWF) to a patient in need thereof. The present invention also relates to a composition comprising vWF and a composition comprising FVIII for simultaneous, separate or sequential use for use in the treatment and/or prevention of a bleeding event associated with a thrombopathy induced by substances inhibiting thrombocytes. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10232015-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9707269-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9125890-B2 |
| priorityDate |
2008-07-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |